A Study of Remote Asthma Management Using an Integrated Artificial Intelligence-assisted EHR Dashboard and Mobile Device Compared With Usual Asthma Care to Treat 6-17 Year Old Patients
| 대상 질환 | Asthma in Children |
|---|---|
| 임상 단계 | 단계 해당 없음 |
| 스폰서 | Mayo Clinic |
| 상태 | 완료 |
| 참여자 수 | 49 명 |
| 중재(약물) | AsthmaTuner, Asthma-Guidance and Prediction System |
| 시작일 | 2023년 12월 5일 |
| 완료일 | 2025년 6월 5일 |
| 결과 공개일 | 2026년 7월 22일 |
요약
The main purpose of this study is to look at whether clinicians and their patients with asthma can satisfactorily perform remote asthma management at home (not visiting clinic) by using an artificial intelligence tool called Asthma-Guidance and Prediction System combined with a home monitoring device called AsthmaTuner.
Change in Satisfaction of Asthma Care
| Pediatric Asthma Intervention Group | 4.5 ± 0.67 score on a scale |
|---|---|
| Pediatric Asthma Control Group | 4.6 ± 0.71 score on a scale |
| Clinician Control Group | 4.3 ± 0.71 score on a scale |
| Clinician Intervention Group | 3.7 ± 0.95 score on a scale |
| Pediatric Asthma Intervention Group | 4.3 ± 1.39 score on a scale |
| Clinician Control Group | 4.2 ± 0.84 score on a scale |
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Developing a Childhood Asthma Risk Passive Digital Marker — Indiana University
- A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With C — Chiesi Farmaceutici S.p.A.
- A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to — Hoffmann-La Roche
- A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Cortic — Hoffmann-La Roche
- Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Sev — AstraZeneca
- Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma — ARS Pharmaceuticals, Inc.